biosante pharmaceuticals inc. Drug Name Bio-T-Gel (NDA) Event Name FDA decision on Bio-T-Gel for treatment of male hypogonadism or low testosterone levels Event Date 02/14/2012 Outcome Drug Status Bio-T-Gel was developed initially by BioSante, and then it was licensed to Teva for late stage clinical development. Teva is responsible for all Bio-T-Gel regulatory and marketing activities. BioSante will receive certain milestone payments and royalties upon commercialization.
Won't sell. Cheaper solution is take teenagers training bra size AAA, extend straps to full length, carry gonads in cups, then when walking or seated in class or watching TV, can message said gonads for 14 waking hours & solve problem over time at no further cost. If triple digit IQ, ask girl in neighborhood or apply to Welfare Board since it's for ones own welfare. Alternatively, can lie daily like POTUS, grow nose to 28", & scratch with nose if hands occupied on computer. THINK MAN - thats what analysts are for.